Exploring Nutritional Supplements for Glaucoma Management: An Overview
Discussing supplements beneficial for glaucoma, the chat highlights niacinamide, flavonoids, forskolin, ginkgo biloba, and CoQ10. Though promising, these require more clinical research. Consultation with a healthcare provider is advised before starting any supplement regimen.
the best glaucoma supplement
When it comes to supplements potentially beneficial for glaucoma, certain nutrients and compounds have shown promise:
-
Niacinamide: This form of Vitamin B3 has been highlighted for its neuroprotective potential in glaucoma. As a neurodegenerative disease, glaucoma may benefit from niacinamide’s ability to protect neuronal populations1.
-
Flavonoids: These compounds, commonly found in various fruits and vegetables, have been noted for potentially improving ocular blood flow and slowing visual field loss2.
-
Forskolin: Known for its intraocular pressure-lowering abilities, forskolin might complement traditional glaucoma therapies2.
-
Ginkgo Biloba: This supplement has been noted for its neuroprotective effects, particularly owing to its antioxidant properties3.
-
Coenzyme Q10: Often recognized for its antioxidant capabilities, CoQ10 might protect retinal ganglion cells, which are affected in glaucoma3.
Other natural products like resveratrol, hesperidin, curcumin, and certain vitamins like Vitamin D have also been studied for potential neuroprotective effects3. However, while these supplements show promise in preliminary studies, comprehensive clinical trials are necessary to establish their efficacy fully. Always consult with a healthcare provider before commencing any supplement regimen, especially for conditions like glaucoma.
Footnotes
-
Shibal Bhartiya, Niacinamide and Neuroprotection: The Glaucoma Holy Grail, PubMed Central, 2022. ↩
-
Ekaterina Loskutova et al., Nutritional supplementation in the treatment of glaucoma: A systematic review, PubMed, 2019. ↩ ↩2
-
Ru Hui Sim, Treatment of Glaucoma with Natural Products and Their Mechanism of Action: An Update, PubMed Central, 2022. ↩ ↩2 ↩3
-